BR112012012023A2 - processo para preparar microcápsulas, microcápsulas, composição, método para tratar uma condição superficial em um indivíduo, e, uso das microcápsulas - Google Patents

processo para preparar microcápsulas, microcápsulas, composição, método para tratar uma condição superficial em um indivíduo, e, uso das microcápsulas

Info

Publication number
BR112012012023A2
BR112012012023A2 BR112012012023A BR112012012023A BR112012012023A2 BR 112012012023 A2 BR112012012023 A2 BR 112012012023A2 BR 112012012023 A BR112012012023 A BR 112012012023A BR 112012012023 A BR112012012023 A BR 112012012023A BR 112012012023 A2 BR112012012023 A2 BR 112012012023A2
Authority
BR
Brazil
Prior art keywords
microcapsules
treating
individual
composition
preparing
Prior art date
Application number
BR112012012023A
Other languages
English (en)
Portuguese (pt)
Inventor
Dorit Marco-Dagan
Haim Bar-Simantov
Hanan Sertchook
Ofer Toledano
Sharon Fireman-Shoresh
Original Assignee
Sol Gel Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sol Gel Technologies Ltd filed Critical Sol Gel Technologies Ltd
Publication of BR112012012023A2 publication Critical patent/BR112012012023A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/38—Percompounds, e.g. peracids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/14—Polymerisation; cross-linking
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BR112012012023A 2009-12-31 2010-12-30 processo para preparar microcápsulas, microcápsulas, composição, método para tratar uma condição superficial em um indivíduo, e, uso das microcápsulas BR112012012023A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29159409P 2009-12-31 2009-12-31
PCT/IL2010/001092 WO2011080741A2 (en) 2009-12-31 2010-12-30 Core stabilized microcapsules, method of their preparation and uses thereof

Publications (1)

Publication Number Publication Date
BR112012012023A2 true BR112012012023A2 (pt) 2016-05-17

Family

ID=44226918

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012012023A BR112012012023A2 (pt) 2009-12-31 2010-12-30 processo para preparar microcápsulas, microcápsulas, composição, método para tratar uma condição superficial em um indivíduo, e, uso das microcápsulas

Country Status (13)

Country Link
US (2) US10512796B2 (enExample)
EP (1) EP2467132B1 (enExample)
JP (1) JP5934107B2 (enExample)
KR (1) KR20130008002A (enExample)
CN (1) CN102596186B (enExample)
AU (1) AU2010337830B2 (enExample)
BR (1) BR112012012023A2 (enExample)
CA (1) CA2773544C (enExample)
EA (1) EA201200347A1 (enExample)
ES (1) ES2611499T3 (enExample)
MX (1) MX344128B (enExample)
WO (1) WO2011080741A2 (enExample)
ZA (1) ZA201203582B (enExample)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5382723B2 (ja) 2007-02-01 2014-01-08 ソル − ゲル テクノロジーズ リミテッド 金属酸化物コーティングを含む粒子の製造方法及び金属酸化物コーティングを有する粒子
KR20110084151A (ko) 2008-07-31 2011-07-21 솔-겔 테크놀로지스 리미티드 활성성분을 포함하는 마이크로캡슐 및 금속 산화물 쉘, 그의 제조방법 및 그의 용도
US10653899B2 (en) 2009-12-31 2020-05-19 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
US11071878B2 (en) 2009-12-31 2021-07-27 Sol-Gel Technologies Ltd. Core stabilized microcapsules, method of their preparation and uses thereof
CN102596186B (zh) 2009-12-31 2017-08-11 索尔-格尔科技有限公司 芯稳定的微胶囊、它们的制备方法以及它们的用途
MX363379B (es) 2011-06-29 2019-03-21 Sol Gel Tech Ltd Formulaciones tópicas estabilizadas que contienen microcápsulas de núcleo-cubierta.
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CN104169054A (zh) * 2012-04-18 2014-11-26 罗门哈斯公司 蜡-杀生物剂的木材处理
US10806697B2 (en) * 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CN102726383B (zh) * 2012-07-05 2015-03-18 常州美胜生物材料有限公司 一种缓释型害虫引诱剂微胶囊及其制备方法
FI126168B (en) 2012-09-18 2016-07-29 Novaldmedical Ltd Oy A method for coating pharmaceutical substrates
CN108159425A (zh) * 2012-11-27 2018-06-15 索尔-格尔科技有限公司 用于治疗红斑痤疮的组合物
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
CN104624125B (zh) * 2013-11-11 2018-03-02 中国人民银行印制科学技术研究所 一种光致变色双壳微胶囊及其制备方法和应用
CN103908912A (zh) * 2014-03-13 2014-07-09 安徽明讯新材料科技有限公司 一种相变恒温配胶容器
US9480960B2 (en) * 2014-12-01 2016-11-01 National Chung Shan Institute Of Science And Technology Process for preparing phase change microcapsule having thermally conductive shell
CN107567326B (zh) * 2015-05-13 2021-03-23 荷兰联合利华有限公司 有益递送颗粒和包含所述颗粒的组合物
CN108024980A (zh) * 2015-08-20 2018-05-11 索尔-格尔科技有限公司 包含过氧化苯甲酰和阿达帕林的用于局部施用的组合物
KR101779846B1 (ko) 2015-08-31 2017-10-10 주식회사 티케이케미칼 나노다공성을 갖는 서방성 미분말과 그 제조방법
CN105754554B (zh) * 2016-02-02 2019-02-19 中南林业科技大学 一种含纳米TiO2的纤维素基低温相变储能微胶囊及其制备方法
WO2017147318A1 (en) 2016-02-23 2017-08-31 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for making and using thermostable immunogenic formulations with increased compatibility of use as vaccines against one or more pathogens
ES2979065T3 (es) * 2016-03-04 2024-09-24 Arkema Inc Encapsulación de peróxidos para aplicaciones cutáneas
CN105797659B (zh) * 2016-04-08 2018-12-14 东南大学 一种二氧化硅壳聚糖双壳储热微胶囊的制备方法
CA3069287C (en) 2017-07-12 2022-08-30 Sol-Gel Technologies Ltd. Methods and compositions for the treatment of acne
US12357602B2 (en) 2017-07-12 2025-07-15 Mayne Pharma Llc Compositions comprising encapsulated tretinoin
CN107213806B (zh) * 2017-07-13 2018-03-06 广州达济医学科技有限公司 一种用于滤除白细胞的滤膜及其制备方法
US11643584B2 (en) * 2017-11-16 2023-05-09 Georgia Tech Research Corporation Incorporation of microencapsulated phase change materials into wet-spin dry jet polymeric fibers
CN111712235A (zh) 2018-01-16 2020-09-25 应用材料公司 金属氧化物包封的药物组合物及其制备方法
CN109338135B (zh) * 2018-10-11 2020-07-14 西北工业大学 一种核壳结构Al@Ti-Al2O3相变蓄热复合材料及制备方法
RU2701030C1 (ru) * 2018-12-29 2019-09-24 Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) Способ получения полых кремнеземных нанокапсул
US10945987B2 (en) 2019-02-19 2021-03-16 Sol-Gel Technologies Ltd. Method for providing early onset of action in the treatment of rosacea
CN120001297A (zh) 2019-04-17 2025-05-16 宝洁公司 胶囊
US11628413B2 (en) 2019-04-17 2023-04-18 The Procter & Gamble Company Methods of making capsules
WO2020214876A1 (en) 2019-04-17 2020-10-22 The Procter & Gamble Company Capsules
CN114080212B (zh) * 2019-07-09 2024-12-27 株式会社Lg生活健康 化妆品用胶囊
JP7132678B2 (ja) * 2019-12-27 2022-09-07 花王株式会社 マイクロカプセルの製造方法
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
KR20230027073A (ko) 2020-05-22 2023-02-27 솔-겔 테크놀로지스 리미티드 안정화된 마이크로캡슐, 그의 제조 방법 및 그의 용도
TWI870622B (zh) 2020-10-02 2025-01-21 美商應用材料股份有限公司 製備氧化矽塗佈藥品的低溫處理
CN116209744A (zh) 2020-10-16 2023-06-02 宝洁公司 衣物护理添加剂颗粒
US12458942B2 (en) 2020-10-16 2025-11-04 The Procter & Gamble Company Capsules
US11938349B2 (en) 2020-10-16 2024-03-26 The Procter & Gamble Company Antiperspirant and deodorant compositions comprising capsules
US12129448B2 (en) 2020-10-16 2024-10-29 The Procter & Gamble Company Water-soluble unit dose article containing a core/shell capsule
EP4653519A2 (en) 2020-10-16 2025-11-26 The Procter & Gamble Company Liquid fabric care compositions comprising capsules
CN112143476B (zh) * 2020-10-21 2022-03-04 南京工业大学 一种采用微流场反应技术制备纳米包覆驱油剂的方法及装置
EP4269550A4 (en) * 2020-12-28 2025-03-26 Kao Corporation PROCESS FOR MANUFACTURING SILICA MICROCAPSULES
CN116635141A (zh) * 2020-12-28 2023-08-22 花王株式会社 微胶囊
EP4408402A4 (en) 2021-09-30 2025-08-06 Applied Materials Inc LOW TEMPERATURE SILICON OXIDE COATING FOR PHARMACEUTICAL APPLICATIONS
CN116919939A (zh) * 2022-04-02 2023-10-24 南京毓浠医药技术有限公司 一种维a酸和过氧化苯甲酰组合物及其制备方法和用途
US12275885B2 (en) * 2022-07-13 2025-04-15 King Fahd University Of Petroleum And Minerals Doped phase change material and method of preparation thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3906108A (en) 1973-10-12 1975-09-16 Johnson & Johnson Stabilized tretinoin cream emulsion
GB9021061D0 (en) 1990-09-27 1990-11-07 Unilever Plc Encapsulating method and products containing encapsulated material
AU697478B2 (en) 1993-02-26 1998-10-08 Estee Lauder Inc. Titanium dioxide dispersions, cosmetic compositions and methods for using the same
US5401517A (en) 1993-11-15 1995-03-28 Elizabeth Arden Company, Division Of Conopco, Inc. Cosmetic method for treatment of skin
US5720949A (en) 1996-05-06 1998-02-24 Bristol-Myers Squibb Company Foamable cosmetic mask product
US5891476A (en) 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
US6337089B1 (en) 1998-02-06 2002-01-08 Seiwa Kasei Company, Limited Microcapsule containing core material and method for producing the same
US6099894A (en) 1998-07-27 2000-08-08 Frisby Technologies, Inc. Gel-coated microcapsules
DE1104287T1 (de) 1998-08-13 2001-12-20 Sol-Gel Technologies Ltd., Tel Aviv Verfahren zur herstellung von mit funktionalisierten molekülen beladene oxid-mikrokapseln und die daraus erhaltenen produkte
US6468509B2 (en) 1998-12-18 2002-10-22 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
US6238650B1 (en) 1999-05-26 2001-05-29 Sol-Gel Technologies Ltd. Sunscreen composition containing sol-gel microcapsules
ATE353210T1 (de) 1999-05-25 2007-02-15 Sol Gel Technologies Ltd Ein verfahren zur herstellung von einem lichtstabilen sonnenschutzmittel
DE10182378T1 (de) 2000-04-21 2012-02-02 Sol-Gel Technologies Ltd. Zusammensetzung mit erhöter Formulationsstabilität und Verabreichung von topischen Wirkstoffen
US7758888B2 (en) * 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
US7923030B2 (en) 2003-03-14 2011-04-12 Sol-Gel Technologies, Inc. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
CA2533406C (en) 2003-07-31 2013-01-22 Sol-Gel Technologies Ltd. Microcapsules loaded with active ingredients and a method for their preparation
DE102004017221A1 (de) 2004-04-05 2005-10-20 Cognis Ip Man Gmbh O/W-Gel-Zusammensetzungen mit Estern des Pentaerythrits oder dessen Oligomeren
EP1750659A1 (de) 2004-04-05 2007-02-14 Cognis IP Management GmbH Wachmischung auf basis von partialglyceriden und pentaerythritestern
KR101158162B1 (ko) * 2005-08-02 2012-06-19 솔-겔 테크놀로지스 리미티드 수 불용성 성분을 금속 산화물로 피복시키는 방법
US9107844B2 (en) 2006-02-03 2015-08-18 Stiefel Laboratories Inc. Topical skin treating compositions
WO2008072239A2 (en) 2006-12-12 2008-06-19 Sol-Gel Technologies Ltd. Formation of nanometric core-shell particles having a metal oxide shell
ES2912051T3 (es) 2007-02-01 2022-05-24 Sol Gel Tech Ltd Composiciones para aplicación tópica que comprenden un peróxido y retinoide
KR100837558B1 (ko) 2007-04-30 2008-06-12 (주)아모레퍼시픽 이중으로 안정된 세라마이드 나노 캡슐 포함 에멀젼조성물, 그의 제조방법 및 이를 이용한 피부 화장료 조성물
ATE518590T1 (de) 2007-05-08 2011-08-15 Givaudan Sa Wachsverkapselung
KR20110084151A (ko) 2008-07-31 2011-07-21 솔-겔 테크놀로지스 리미티드 활성성분을 포함하는 마이크로캡슐 및 금속 산화물 쉘, 그의 제조방법 및 그의 용도
CN102596186B (zh) 2009-12-31 2017-08-11 索尔-格尔科技有限公司 芯稳定的微胶囊、它们的制备方法以及它们的用途

Also Published As

Publication number Publication date
CA2773544C (en) 2019-02-12
CN102596186B (zh) 2017-08-11
KR20130008002A (ko) 2013-01-21
JP2013516404A (ja) 2013-05-13
EP2467132B1 (en) 2016-10-19
MX344128B (es) 2016-12-06
US10512796B2 (en) 2019-12-24
WO2011080741A2 (en) 2011-07-07
CA2773544A1 (en) 2011-07-07
MX2012006636A (es) 2012-07-10
US20180117369A1 (en) 2018-05-03
AU2010337830A1 (en) 2012-03-22
EA201200347A1 (ru) 2012-07-30
CN102596186A (zh) 2012-07-18
ES2611499T3 (es) 2017-05-09
US20120202695A1 (en) 2012-08-09
AU2010337830B2 (en) 2013-10-03
ZA201203582B (en) 2013-01-30
JP5934107B2 (ja) 2016-06-15
EP2467132A2 (en) 2012-06-27
WO2011080741A3 (en) 2011-10-13

Similar Documents

Publication Publication Date Title
BR112012012023A2 (pt) processo para preparar microcápsulas, microcápsulas, composição, método para tratar uma condição superficial em um indivíduo, e, uso das microcápsulas
CL2013001982A1 (es) Metodo para reducir los niveles de glucosa y tratar trastornos del metabolismo de la misma; composicion farmaceutica que comprende metformina y otro agente antidiabetico o antiobesidad.
BR112013022246A2 (pt) formulações para alisamento capilar a base de queratina, métodos e sistemas
BRPI0700678A (pt) método para aperfeiçoar comportamentos de sono
BRPI0916820A2 (pt) processo para preparar microcápsulas, microcápsulas, composição, método para tratar uma condição de superfície em um paciente, e, uso de microcápsulas
BR112015005940A2 (pt) processo para a preparação de nanopartículas terapêuticas
BR112017023380A2 (pt) sistema, composição cosmética, métodos para tratamento de substratos queratinosos e para proteção e/ou alisamento da fibra do cabelo, kit multicompartimento, e, processo para alisamento do cabelo.
BR112013029422A2 (pt) cápsulas núcleo-revestimento
BR112013018352A2 (pt) composição de minociclina tópica e método
BR112015010182A2 (pt) processo para alisamento e tingimento de cabelo
BRPI0925036B8 (pt) uso de trans-t-butil ciclo-hexanol, composição cosmética, medicamento, seus usos e processos para tratar irritação na pele
CL2007003356A1 (es) Compuestos derivados de benzopirazoles; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para el tratamiento del asma, inflamacion, entre otras enfermedades.
CL2012000958A1 (es) Producto consumible por calor sin combustión que comprende un agente generador de aerosol encapsulado; uso de un agente generador de aerosol encapsulado en dicho producto consumible; y método para controlar la liberación de un agente generador de aerosol.
BR112012006965A2 (pt) Cosmético sob a forma de espuma
PE20081684A1 (es) Microcapsulas vegetarianas
BR112015006469A2 (pt) microcápsulas de núcleo/casca de múltiplas camadas
MX2016004091A (es) Metodo de alisado para el cabello que implica azucares reductores.
BR112018010136A8 (pt) microcápsulas, dispersão de microcápsulas, processo para a preparação das microcápsulas e método para o controle de fungos fitopatogênicos
BR112018073298A2 (pt) cápsula, suspensão de cápsula, mistura, uso das cápsulas e método para reduzir a nitrificação
BR112015024958A2 (pt) composição e processos cosméticos
CL2011002648A1 (es) Composicion topica que comprende un compuesto derivado de 1,2,4-tiadiazol o tiourea, un agente modificador de la viscosidad, un conservante y agua; estuche para la composicion; metodo para preparar la composicion; y uso para tratar una enfermedad o trastorno dermatologico mediado por un receptor de melanocortina tal como acne.
BRPI0915439B8 (pt) composição de gel tópica, bem como uso de um agente ativo para tratamento de ceratose actínica em combinação com um agente ceratoliticamente ativo para preparação da referida composição
BR112014029885A8 (pt) Composições tópicas, que contêm um retinoide, de tipo emulsão óleo em água
BR112016014305B8 (pt) Lenço com gel e método para fabricar um lenço com gel
CL2014002591A1 (es) Composicion topica semisolida que comprende pirfenidona, dialil oxido de disulfuro modificado (odd-m), un agente gelificante y otros excipientes o aditivos; proceso para fabricarla; metodo de tratamiento; y su uso para eliminar, reducir o prevenir el acne.

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2383 DE 06-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.